Drugs / CD1c(BDCA-1)+ /CD141(BDCA-3)+ myDC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03233152 | Nov 2016 → Nov 2026 expected | glioblastoma | University Hospital Brussels | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD1c(BDCA-1)+ /CD141(BDCA-3)+ myDC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03233152 ↗ |
| Route | Other | “These are injected in the neighbouring brain tissue post tumor resection” NCT03233152 ↗ |